Therapeutic potential of curcumin for multiple sclerosis

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Munibah QureshiAdeeb Shehzad

Abstract

Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS), characterized by demyelination, neuronal injury, and breaching of the blood-brain barrier (BBB). Epidemiological studies have shown that immunological, genetic, and environmental factors contribute to the progression and development of MS. T helper 17 (Th17) cells are crucial immunological participant in the pathophysiology of MS. The aberrant production of IL-17 and IL-22 by Th17 cells crosses BBB promotes its disruption and interferes with transmission of nerve signals through activation of neuroinflammation in the CNS. These inflammatory responses promote demyelination through transcriptional activation of signal transducers and activators of transcription-1 (STAT-1), nuclear factor kappa-B (NF-κB), matrix metalloproteinases (MMPs), interferon ϒ (IFNϒ), and Src homology region 2 domain-containing phosphatase-1 (SHP-1). B cells also contribute to disease progression through abnormal regulation of antibodies, cytokines, and antigen presentation. Additionally, oxidative stress has been known as a causative agent for the MS. Curcumin is a hydrophobic yellowish diphenolic component of turmeric, which can interact and modulate...Continue Reading

References

Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chandramohan Natarajan, John J Bright
Oct 22, 2003·Journal of the Neurological Sciences·Jifen LiMalek Kamoun
Oct 16, 2004·Immunity·Jay K Kolls, Anders Lindén
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gi-Young KimYeong-Min Park
Nov 2, 2005·Cellular and Molecular Life Sciences : CMLS·D MiljkovicV Trajkovic
Oct 13, 2006·Annual Review of Pharmacology and Toxicology·Sten OrreniusBoris Zhivotovsky
May 8, 2007·Annals of the New York Academy of Sciences·Gábor BánhegyiWei Yang
Jul 25, 2007·Seminars in Cell & Developmental Biology·Smriti M AgrawalV Wee Yong
Jan 22, 2008·Journal of Clinical Psychopharmacology·Aashish R ParikhBarry I Liskow
Mar 19, 2008·The Journal of Experimental Medicine·Thaddeus CarlsonBenjamin Segal
Apr 29, 2009·Laboratory Investigation; a Journal of Technical Methods and Pathology·George P ChristophiPaul T Massa
May 13, 2009·Proceedings of the National Academy of Sciences of the United States of America·Wassim ElyamanSamia J Khoury
Aug 12, 2009·Current Neurology and Neuroscience Reports·Kimmy G SuMichael Forte
Nov 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anneli JägerVijay K Kuchroo
Nov 27, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jula HuppertChristoph R W Kuhlmann
Oct 20, 2010·Current Drug Targets·Hongyu ZhouShile Huang
Feb 23, 2011·Scandinavian Journal of Immunology·F Jadidi-Niaragh, A Mirshafiey
Mar 10, 2012·The Journal of Nutritional Biochemistry·Saravanan KanakasabaiJohn J Bright
Mar 14, 2012·Cellular and Molecular Neurobiology·Zhi-Jun ZhangChunlin Xia
Jun 7, 2012·Journal of the Neurological Sciences·Antonio FedericoElena Radi
Oct 3, 2012·Nature Reviews. Neurology·Gloria von Geldern, Ellen M Mowry
Dec 26, 2012·Neurochemistry International·Marcelo FarinaMichael Aschner
Jan 11, 2013·BioFactors·Adriana MonroySilvestre Alavez
Jul 13, 2013·CNS & Neurological Disorders Drug Targets·Hong-Fang Ji, Liang Shen
Jan 3, 2014·Experimental Neurology·Million Adane TegengeArun Venkatesan
Feb 11, 2014·Handbook of Clinical Neurology·Alexandra Kutzelnigg, Hans Lassmann
Feb 12, 2014·Sultan Qaboos University Medical Journal·Abbas MirshafieyGholamreza Azizi
May 29, 2014·Oxidative Medicine and Cellular Longevity·Jinzhou FengXinyue Qin
Jun 3, 2014·Acta Neuropathologica Communications·Gillian IngramB Paul Morgan
Jul 8, 2014·International Immunopharmacology·Mir Hadi SeyedzadehMohammad Reza Khorramizadeh
Sep 18, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Eleonora TavazziMarco Rovaris
Nov 29, 2014·Archives of Medical Research·Genaro Gabriel OrtizMoisés Alejandro Alatorre-Jiménez
Dec 4, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Kavirayani Indira Priyadarsini

❮ Previous
Next ❯

Citations

Feb 28, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Antonio Federico
Nov 30, 2018·Endocrine, Metabolic & Immune Disorders Drug Targets·Mahsa HatamiNiyaz Mohammadzadeh Honarvar
Jun 12, 2019·BioFactors·Abid BhatMeena K Sakharkar
Jan 13, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ilaria Di Donato, Antonio Federico
Feb 9, 2020·Journal of Clinical Medicine·Bahare SalehiJavad Sharifi-Rad
Mar 4, 2020·Journal of Biochemical and Molecular Toxicology·Mukesh MandalAwanish Mishra
Mar 19, 2020·Journal of Clinical Medicine·Sonia MissiroliCarlotta Giorgi
Dec 12, 2018·Journal of Cellular Physiology·Negar GhanaatianAmirhossein Sahebkar
Jan 20, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Tanja Grubić KezeleDinko Štimac
Oct 16, 2019·Current Pharmaceutical Design·Adeeb ShehzadEbtesam A Al-Suhaimi
Mar 20, 2018·Current Treatment Options in Neurology·Leah J Mische, Ellen M Mowry
Apr 6, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sathish Sundar Dhilip KumarHeidi Abrahamse
Aug 8, 2018·Neuropharmacology·Ruchira M JhaJ Marc Simard
Sep 17, 2021·Phytotherapy Research : PTR·Maryam MohseniMohammad Bagherniya
Jan 13, 2022·Neural Regeneration Research·Fatemeh ZahedipourAmirhossein Sahebkar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here